{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:35:25Z","timestamp":1793061325230,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC10988"],"award-info":[{"award-number":["FC10988"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC010110"],"award-info":[{"award-number":["FC010110"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["18\/SPP\/3522"],"award-info":[{"award-number":["18\/SPP\/3522"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA247439"],"award-info":[{"award-number":["U01 CA247439"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016916","name":"Royal Marsden Cancer Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["A2204"],"award-info":[{"award-number":["A2204"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"The Francis Crick Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013920","name":"VHL Alliance","doi-asserted-by":"publisher","award":["PRJ_20450"],"award-info":[{"award-number":["PRJ_20450"]}],"id":[{"id":"10.13039\/100013920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["W81XWH-22-1-0652"],"award-info":[{"award-number":["W81XWH-22-1-0652"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["686061"],"award-info":[{"award-number":["686061"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research","doi-asserted-by":"publisher","award":["A109"],"award-info":[{"award-number":["A109"]}],"id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xcrm.2026.102981","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:12:40Z","timestamp":1786115560000},"page":"102981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-3346","authenticated-orcid":false,"given":"Donagh","family":"Egan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Fidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kolch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lobon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-136X","authenticated-orcid":false,"given":"Samra","family":"Turajlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102981_bib1","first-page":"1974","article-title":"Immune Checkpoint Blockade in Cancer Therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.xcrm.2026.102981_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2407417","article-title":"Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma","volume":"392","author":"Wolchok","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102981_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib4","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102981_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s43018-021-00221-9","article-title":"Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma","volume":"2","author":"Haas","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102981_bib6","first-page":"43","article-title":"Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction","volume":"4","author":"Qiu","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102981_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","article-title":"Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer","volume":"42","author":"Memon","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib8","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41467-023-36979-y","article-title":"The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma","volume":"14","author":"Lim","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102981_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nmeth.1439","article-title":"Cell type\u2013specific gene expression differences in complex tissues","volume":"7","author":"Shen-Orr","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102981_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","article-title":"Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology","volume":"3","author":"Chu","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102981_bib11","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1158\/0008-5472.CAN-20-2352","article-title":"Pan-Cancer Analysis of Ligand\u2013Receptor Cross-talk in the Tumor Microenvironment","volume":"81","author":"Ghoshdastider","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102981_bib12","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1158\/0008-5472.CAN-18-3560","article-title":"Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods","volume":"79","author":"Jim\u00e9nez-S\u00e1nchez","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102981_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omto.2021.11.016","article-title":"Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges","volume":"24","author":"Poggi","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.xcrm.2026.102981_bib15","article-title":"Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma","volume":"3","author":"Freeman","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102981_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41591-020-01211-7","article-title":"Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma","volume":"27","author":"Rozeman","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102981_bib17","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","article-title":"Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102981_bib18","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102981_bib19","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1038\/s41467-019-09990-5","article-title":"Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures","volume":"10","author":"Zaitsev","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102981_bib20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102981_bib21","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102981_bib26","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/ncomms5011","article-title":"De novo SOX11 mutations cause Coffin\u2013Siris syndrome","volume":"5","author":"Tsurusaki","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102981_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12887-022-03535-4","article-title":"Short stature and melanocytic nevi in a girl with ARID1B-related Coffin-Siris syndrome: a case report","volume":"22","author":"Tao","year":"2022","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.xcrm.2026.102981_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jdcr.2018.08.024","article-title":"Vitiligo and melanocytic nevi: New findings in Coffin-Siris syndrome associated with ARID1 germline mutation","volume":"5","author":"Tchanque-Fossuo","year":"2019","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.xcrm.2026.102981_bib29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ajmg.a.61075","article-title":"Patient with anomalous skin pigmentation expands the phenotype of ARID2 loss-of-function disorder, a SWI\/SNF-related intellectual disability","volume":"179","author":"Khazanchi","year":"2019","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.xcrm.2026.102981_bib30","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.devcel.2021.08.006","article-title":"UV-induced reduction in Polycomb repression promotes epidermal pigmentation","volume":"56","author":"Li","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib31","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/art.37964","article-title":"Autoantibodies to Posttranslationally Modified Type II Collagen as Potential Biomarkers for Rheumatoid Arthritis","volume":"65","author":"Strollo","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.xcrm.2026.102981_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature11538","article-title":"Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation","volume":"490","author":"Landsberg","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102981_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145859","article-title":"Melanoma dedifferentiation induced by IFN-\u03b3 epigenetic remodeling in response to anti\u2013PD-1 therapy","volume":"131","author":"Kim","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102981_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","article-title":"A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma","volume":"187","author":"Pozniak","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc2328","article-title":"MYC in mammalian epidermis: how can an oncogene stimulate differentiation?","volume":"8","author":"Watt","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102981_bib34","doi-asserted-by":"crossref","first-page":"11958","DOI":"10.1073\/pnas.0601886103","article-title":"Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence","volume":"103","author":"Jensen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102981_bib35","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1101\/gad.11.21.2869","article-title":"c-Myc promotes differentiation of human epidermal stem cells","volume":"11","author":"Gandarillas","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2026.102981_bib36","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41417-021-00424-3","article-title":"Protooncogene MYC drives human melanocyte melanogenesis and senescence","volume":"29","author":"San Juan","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102981_bib37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/embr.201337424","article-title":"MYC proteins promote neuronal differentiation by controlling the mode of progenitor cell division","volume":"15","author":"Zinin","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.xcrm.2026.102981_bib38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102981_bib40","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110253","article-title":"BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changes","volume":"27","author":"Arifin","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2026.102981_bib42","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102981_bib44","article-title":"Targeting Interferon-Driven Inflammatory Memory Prevents Epigenetic Evolution of Cancer Immunotherapy Resistance","author":"Qiu","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.102981_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110582","article-title":"PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade","volume":"38","author":"Srour","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102981_bib46","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant\u2013Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102981_bib48","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa2402604","article-title":"Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma","volume":"391","author":"Blank","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102981_bib49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1523-1747.2002.01754.x","article-title":"Rab27b Association with Melanosomes: Dominant Negative Mutants Disrupt Melanosomal Movement","volume":"118","author":"Chen","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.xcrm.2026.102981_bib50","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/pr060363j","article-title":"Proteomic and Bioinformatic Characterization of the Biogenesis and Function of Melanosomes","volume":"5","author":"Chi","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.xcrm.2026.102981_bib51","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102981_bib52","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s43018-024-00752-x","article-title":"Tissue-specific thresholds of mutation burden associated with anti-PD-1\/L1 therapy benefit and prognosis in microsatellite-stable cancers","volume":"5","author":"Muquith","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102981_bib53","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","author":"Akbani","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib54","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102981_bib55","article-title":"Antigenic cancer persister cells survive direct T cell attack","author":"Wang","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.102981_bib56","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102981_bib57","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-22-0563","article-title":"Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma","volume":"11","author":"Egan","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102981_bib58","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccell.2020.08.005","article-title":"Conserved Interferon-\u03b3 Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma","volume":"38","author":"Grasso","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib59","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s43018-021-00180-1","article-title":"Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy","volume":"2","author":"Han","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102981_bib60","article-title":"NF-\u03baB activation enhances STING signaling by altering microtubule-mediated STING trafficking","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102981_bib61","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/s41467-024-47425-y","article-title":"Molecular patterns of resistance to immune checkpoint blockade in melanoma","volume":"15","author":"Lauss","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102981_bib62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","article-title":"Pan-cancer whole-genome analyses of metastatic solid tumours","volume":"575","author":"Priestley","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102981_bib63","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102981_bib64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.102981_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.xcrm.2026.102981_bib66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102981_bib67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102981_bib68","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102981_bib69","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","article-title":"Robust and scalable single-cell gene signature scoring","volume":"19","author":"Andreatta","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.xcrm.2026.102981_bib70","author":"Renevey"},{"key":"10.1016\/j.xcrm.2026.102981_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102981_bib72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1101\/gr.257246.119","article-title":"Accurate and efficient detection of gene fusions from RNA sequencing data","volume":"31","author":"Uhrig","year":"2021","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2026.102981_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006453","article-title":"Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression","volume":"15","author":"Bendall","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.xcrm.2026.102981_bib74","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene Set Knowledge Discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.xcrm.2026.102981_bib75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41592-021-01142-2","article-title":"TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data","volume":"18","author":"Song","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102981_bib76","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2019.08.032","article-title":"UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma","volume":"179","author":"Wolf","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib77","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows\u2013Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102981_bib78","article-title":"Scalable and efficient DNA sequencing analysis on different compute infrastructures aiding variant discovery","volume":"6","author":"Hanssen","year":"2024","journal-title":"NAR Genom. Bioinf."},{"key":"10.1016\/j.xcrm.2026.102981_bib79","article-title":"Calling Somatic SNVs and Indels with Mutect2","author":"Benjamin","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.102981_bib80","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","article-title":"The Life History of 21 Breast Cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102981_bib81","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1186\/s12859-020-03919-2","article-title":"PyClone-VI: scalable inference of clonal population structures using whole genome data","volume":"21","author":"Gillis","year":"2020","journal-title":"BMC Bioinf."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:28:33Z","timestamp":1793060913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666379126003988"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102981","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102981"}}